1 0 1 7 a r t I C l e S Zinc is essential for life and is the second most prevalent trace element in the body, after iron. This heavy metal is crucially involved in cellular metabolism, and detrimental consequences of zinc deficiency in human nutrition and public health have been well recognized since the 1960s 1 . Most zinc is bound to metalloproteins and contributes to enzymatic catalysis or structural stability 1 . Zinc is particularly abundant in the CNS. A substantial amount of neural zinc (~10%) is found in axon terminals of neurons in a chelatable ionic form (Zn 2+ ) 2 . CNS chelatable Zn 2+ is mostly sequestered in synaptic vesicles of glutamatergic neurons, and release of Zn 2+ with glutamate has been proposed to modulate both excitatory and inhibitory synaptic transmission and plasticity [3] [4] [5] [6] . This observation led many authors to propose a role for zinc in brain functions, such as motor control 7 , and in neurological disorders 2, 8 , including in pathological pain 9, 10 . At present, however, the physiological importance of synaptic zinc remains largely unknown. A major hurdle in the study of synaptic zinc physiology is the myriad of potential zinc targets, which include several voltagedependent ion channels and principal neurotransmitter transporters and receptors 8, [11] [12] [13] . On these targets, zinc can exert either positive or negative modulatory effects with degrees of potency that vary considerably. Effects of zinc are thus expected to be many and complex, both increasing and decreasing neuronal excitability.
are heteromeric assemblies composed mainly of NR1 and NR2 subunits, and they form glutamate-gated ion channels with biophysical and pharmacological properties largely determined by the type of NR2 subunit: type A, B, C or D 14 . In particular, the NR2A subunit, which is widely expressed in the adult nervous system, confers to NMDARs an exquisite sensitivity for extracellular zinc. The NR2A clamshell-like N-terminal domain contains a high-affinity Zn 2+ binding site, which mediates allosteric inhibition of NR2A-containing NMDARs by nanomolar zinc concentrations 17, 18 . Functional and modeling studies on recombinant NMDARs have identified several residues that are essential for Zn 2+ binding to the NR2A N-terminal domain. This is the case for His128, whose mutation strongly reduces Zn 2+ affinity (a ~1,000-fold shift in the half-maximum inhibitory concentration), whereas other receptor properties-including agonist (glutamate and glycine) sensitivity, channel maximal open probability, Mg 2+ block and proton inhibition-are unaffected [18] [19] [20] [21] . To investigate the importance of zinc action on NMDARs in vivo, we generated mutant mice carrying the H128S mutation on the NMDAR NR2A subunit. Here, we show that the Zn 2+ -NR2A interaction is a key molecular event that regulates major aspects of pain processing.
RESULTS

Generation and characterization of NR2A H128S knock-in mice
We generated knock-in mutant mice harboring a histidine-to-serine point mutation at position 128 of the NR2A subunit (NR2A-H128S mutation) to assess the physiological relevance of Zn 2+ acting at NR2A subunits in vivo. We used homologous recombination to introduce Zinc is abundant in the central nervous system and regulates pain, but the underlying mechanisms are unknown. In vitro studies have shown that extracellular zinc modulates a plethora of signaling membrane proteins, including NMDA receptors containing the NR2A subunit, which display exquisite zinc sensitivity. We created NR2A-H128S knock-in mice to investigate whether Zn 2+ -NR2A interaction influences pain control. In these mice, high-affinity (nanomolar) zinc inhibition of NMDA currents was lost in the hippocampus and spinal cord. Knock-in mice showed hypersensitivity to radiant heat and capsaicin, and developed enhanced allodynia in inflammatory and neuropathic pain models. Furthermore, zinc-induced analgesia was completely abolished under both acute and chronic pain conditions. Our data establish that zinc is an endogenous modulator of excitatory neurotransmission in vivo and identify a new mechanism in pain processing that relies on NR2A NMDA receptors. The study also potentially provides a molecular basis for the pain-relieving effects of dietary zinc supplementation.
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We first assessed the effects of the NR2A-H128S mutation at the tissue level (Fig. 2) . To determine whether NMDARs from NR2A-H128S mutant mice are insensitive to low (nanomolar) zinc concentrations, we transplanted forebrain membrane extracts into Xenopus laevis oocytes and measured resulting NMDA currents. High-affinity zinc inhibition of NMDA currents was lost (Fig. 2a) , demonstrating that the targeting strategy was successful. Furthermore, sensitivity to ifenprodil, an NR2B-selective antagonist 14 , was indistinguishable between wild-type (WT) and knock-in preparations, indicating that proportions of NR2A versus NR2B subunits were maintained in mutant mice (Fig. 2a) . We then measured NMDA excitatory postsynaptic currents (EPSCs) in acute slices from the hippocampus, which possesses zinc-containing neuron terminals at high density 2, 8 , and from the spinal cord, which is a main site for pain processing. In both slice preparations, and in line with our observation in oocytes, NMDA EPSCs from WT mice were markedly inhibited by exogenous Figure 1 Targeting the NMDA receptor NR2A subunit gene in mice. (a) The NR2A-H128S mutant allele was created by homologous recombination. The scheme shows the WT NR2A allele, the targeting vector, the targeted allele and the H128S knock-in allele. The CAT codon encoding histidine 128 (H128) in exon 1 was replaced by the TCC codon encoding serine (S), and a loxP-flanked ('floxed') neo cassette was introduced 3′ from exon 1 to select for embryonic stem cells harboring the knock-in allele. The final mutant allele was obtained after excision of the neo cassette by a Cre recombinase treatment of embryonic stem cells. White box, exon 1; star in white box shows the H128S mutation; dark line, intronic sequences; Ba, BamH I; Bs, Bsu361; Sp, SpeI (restriction sites); triangles, loxP sites; neo box, neomycin-resistance cassette; gray bars, probes for Southern blot analysis; lines above gene indicate expected labeled DNA fragments in Southern blot analysis. (b) Southern blot analysis of WT and targeted alleles in the selected embryonic stem cell clone. Genomic DNA was digested with Bsu361 and BamHI, and hybridized with 5′ and 3′ external probes, respectively or the neo probe. Expected bands at each size as indicated in a are obtained. (c) Genomic DNA sequence analysis using tail biopsies from WT (left panel) and knock-in homozygous mutant (right panel) mice, showing the replacement of the CAT codon by the mutated TCC codon. (d) Genotyping of the NR2A-H128S knock-in line. PCR analysis using mutation-specific primers (strategy on left) reveals WT (280 bp) and mutant (315 bp) alleles (right). White arrow, forward primer for WT DNA, black arrow, forward primer for mutant DNA, gray arrows, reverse primer. Analysis of genomic DNA from WT NR2A, homozygous NR2A-H128S and heterozygous NR2A WT/NR2A-H128S mice is shown. The 35-bp differences between mutant and WT alleles results from the remaining loxP site in the mutant allele. Figure 2 High-affinity zinc inhibition of NMDA currents is lost in NR2A-H128S mice. (a) Sensitivity to subunit-specific modulators of brain NMDARs from WT and knock-in NR2A-H128S (KI) mice transplanted into Xenopus oocytes. Inhibition by 20 nM zinc was abolished in KI mice (upper traces; 2.3 ± 1.3%, n = 6 versus 30.3 ± 4.2% n = 10 for WT; mean ± s.d., *P < 0.001, Student's t-test), whereas inhibition by the NR2B-selective antagonist ifenprodil was unchanged (lower traces; 25.2 ± 3.2%, n = 6 versus 24.8 ± 2.4% n = 13 for WT; P = 0.7). NMDA currents were induced by co-application of 300 µM NMDA, 100 µM glycine and 10 µM strychnine (N + G + S). (b) Hippocampal Schaeffer collateral to CA1 NMDA EPSCs from KI mice were insensitive to 300 nM zinc, contrasting with the marked inhibition seen in WT mice (peak current ratio: 0.48 ± 0.03 n = 4 versus 0.93 ± 0.06 n = 5 for KI; *P < 0.001, Student's t-test). Same for NMDA EPSCs recorded in the dorsal horn of the spinal cord (0.59 ± 0.05, n = 6 for WT versus 1.03 ± 0.07, n = 6 for KI; mean ± s.d., *P < 0.001). (c) Unaltered protein expression levels in KI mice compared with those of WT mice in forebrain (top) and spinal cord (bottom). Lower band, α-tubulin control (α-tub). Full-length blots are presented in Supplementary Figure 1 . For each protein, quantification was performed on two or three different WT-KI couples; no significant changes in expression was detected (P > 0.05, one-sample Student's t-test; see Supplementary Fig. 2 ). a r t I C l e S submicromolar zinc applications, whereas NMDA EPSCs from knockin mice were barely affected (Fig. 2b) . Hence, the NR2A-H128S mutation ablates high-affinity zinc modulation of NMDARs in vivo. Together, these data provide unambiguous evidence that NMDARs endogenously expressed in their native synaptic environment are highly sensitive to extracellular zinc, as previously shown in recombinant systems 17 .
In contrast to these robust effects on zinc sensitivity, the mutation did not alter expression levels, in either the forebrain or spinal cord, of NR2A, NR2B or NR1 subunits, or those of AMPA receptors (GluR1 subunit), glycine receptors (GlyRα1 subunit) or the vesicular zinc transporter (ZnT3 (ref. 23)) ( Fig. 2c and Supplementary Figs. 1  and 2) . Moreover, the NR2B-selective antagonist Ro256981 (ref. a r t I C l e S same extent (percentage of inhibition: 47 ± 2% (n = 4) for knock-in versus 53 ± 3% (n = 3) for WT, P = 0.19, Student's t-test) revealing that the proportion of synaptic NR2A-versus NR2B-containing NMDA receptors was unaltered in mutant mice. Similarly, the presence of the NR2A-H128S mutation did not significantly change the synaptic time course of hippocampal NMDA EPSCs (P = 0.9, Student's t-test; Supplementary Fig. 3a) . Furthermore, Timm's staining, which labels chelatable zinc, was identical in brain sections from knock-in and WT mice (Supplementary Fig. 3b) . Thus, high-affinity zinc modulation of NMDARs was specifically eliminated in NR2A-H128S mice, whereas the abundance of main excitatory glutamate receptors, the inhibitory glycine receptor (another target of zinc 7 ) and synaptic zinc remained unaltered.
Pain responses in NR2A-H128S knock-in mice
We conducted neurological examinations of NR2A-H128S mice. Mutants showed a general health comparable with WT mice (well groomed coats and normal body posture, muscle strength, body weight, body temperature, general sensory functions-including olfactory, auditory and visual functions-food consumption and locomotor exploration (Supplementary Table 1) ). In addition, locomotor habituation in a novel environment and the circadian pattern of locomotor behavior were indistinguishable between mutants and controls ( Supplementary Fig. 4) . Altogether, no major signs of behavioral abnormalities were detected in NR2A-H128S mutant mice.
To investigate whether endogenous Zn 2+ binding to NR2A subunits is involved in pain control, we examined pain sensitivity in mutant mice (Fig. 3) . Acute nociception in tail immersion and hot plate tests (Fig. 3a,b) , as well as tail pressure and von Frey tests (Fig. 3e,f) were unchanged, but mutant mice showed increased responses to radiant heat (tail flick and Hargreaves tests) (Fig. 3c,d ). This hypersensitivity was observed only at heat rates of 0.9 or 2.2 °C s −1 but not at 4.0 °C s −1 (Fig. 3g) , revealing a thermal hypersensitivity under slow heat pain stimulation. The mechanisms underlying responses to distinct pain stimuli are complex and recruit multiple primary afferent neurons 24 . Slow heating conditions (tail flick test at 0.9 or 2.2 °C s −1 and Hargreaves test) mainly stimulate nociceptive C fibers, whereas fast heating conditions (tail flick test at 4.0 °C s −1 , tail immersion and and mechanical allodynia (VF, right panels). These antihyperalgesic and antiallodynic effects were absent in mutant mice. (e,f) SNL neuropathic pain. As for inflammatory pain, both i.t. or s.c. zinc inhibited thermal hyperalgesia (HT, left panels) and mechanical allodynia (VF, right panels) induced by sciatic nerve ligation. These antihyperalgesic and antiallodynic effects were absent in KI mice. For both CFA and SNL experimental series, data are expressed as means ± s.e.m. of eight mice per group. ***P < 0.001 for zinc-treated versus saline-treated groups, § § § P < 0.001 for mutants versus controls, two-way repeated measures analysis of variance (ANOVA) followed by Bonferroni-Dunn test.
a r t I C l e S hot plate tests) preferentially recruit Aδ fibers 25, 26 . Altogether, these observations suggest that endogenous Zn 2+ binding to NR2A subunits inhibits C fibers rather than Aδ fibers. This is consistent with the notion that excitation of C fibers, but not Aδ fibers, leads to increased NMDAR function in target spinal cord neurons 16, 27 . To further investigate the involvement of C and Aδ fibers, we tested mutant mice for tonic pain responses induced either by capsaicin (a TRPV1 activator that preferentially activates unmyelinated C fibers) and TIP39 (a parathyroid hormone 2 receptor agonist that selectively activates myelinated nociceptive A fibers) 28 . NR2A-H128S mice showed clear hypersensitivity to capsaicin but not to TIP39 (Fig. 3h-j) , indicating that disruption of the Zn 2+ -NR2A interaction enhances C-fiber excitability. Therefore, endogenous Zn 2+ binding to NR2A limits NMDAR-regulated excitability mainly at the level of C fibers.
As NMDA receptors are important actors of chronic pain development 15, 16 , we examined chronic pain responses of NR2A-H128S mice. We used two well established models of chronic pain, namely complete Freund's adjuvant (CFA)-induced inflammatory pain and partial sciatic nerve ligation (SNL)-induced neuropathic pain (Fig. 4) . In WT mice, both CFA intraplantar administration and SNL induced significant (P < 0.001, Student's t-test) hypersensitivity to heat (heat hyperalgesia in the Hargreaves test) and tactile stimuli (mechanical allodynia in von Frey measures). In mutant mice, thermal sensitivity to radiant heat was higher at the basal state under both conditions, as observed in the acute pain experiments. However, after CFA and SNL, heat hyperalgesia developed with comparable intensities in both genotypes, and the two groups recovered similarly at day 14 (CFA; Fig. 4a ) and week 10 (SNL; Fig. 4b) , suggesting that chronic pain-induced hyperalgesia did not differ between genotypes. By contrast, the amplitude and duration of mechanical allodynia were both strongly increased in mutants, and the enhanced mechanical sensitivity of mutant mice was observed in response to both CFA and SNL (Fig. 4c,d ). There was otherwise no change in pain sensitivity at contralateral paws or in sham control mice in any chronic pain model (Supplementary Figs. 5 and 6) . Together, these results demonstrate that the NR2A-H128S mutation specifically increases mechanical allodynia under conditions of persistent pain. Binding of endogenous Zn 2+ to the NR2A subunit, therefore, reduces mechanical sensitivity as chronic pain develops.
Why Zn 2+ -NR2A binding contributes to reduce chronic pain mainly in the mechanical modality remains open. A large body of evidence indicates that NMDARs are overstimulated under conditions of chronic pain 15, 16 , a phenomenon that influences several signaling pathways 29 . Future studies will determine the main downstream effectors in the pain-reducing effect of zinc, including the well established neuronal cyclooxygenase-2 pathway 30 that is known to modulate mechanical sensitivity 31 .
Analgesic effects of exogenous zinc in NR2A-H128S mice We investigated the analgesic effects of exogenous zinc in WT and NR2A-H128S knock-in mouse littermates (Fig. 5 and Supplementary  Figs. 7 and 8) . We used the tail flick test, the inflammatory model and the neuropathic pain model. Low doses of zinc were administered to avoid the toxicity associated with high zinc dosage 32 . WT mice responded strongly to zinc. Indeed, both intrathecal and subcutaneous zinc increased tail withdrawal latency in the tail flick test (Fig. 5a,b) , in agreement with a previous report 33 . Moreover, zinc administration almost completely reversed thermal hyperalgesia and mechanical allodynia in both CFA (Fig. 5c,d) and SNL (Fig. 5e,f) models of chronic pain. The effect of zinc was observed at a time point at which inflammatory and neuropathic pain had fully developed.
These results confirm that both local and systemic injections of lowdose zinc produce pronounced analgesia in rodents [33] [34] [35] and uncover a remarkably robust effect of zinc under conditions of chronic pain.
In contrast, zinc was totally ineffective in NR2A-H128S knock-in mice. Zinc did not modify tail withdrawal responses to acute heat stimulation (Fig. 5a,b) . Furthermore, neither thermal nor mechanical responses were altered by zinc administration in both inflammatory (Fig. 5c,d) and neuropathic (Fig. 5e,f) pain models. Overall, the NR2A-H128S mutation abolished all the pain-reducing effects of zinc that were tested. The lack of zinc effects in mutant mice unequivocally demonstrates that binding of high-affinity Zn 2+ to NR2A subunit is essential for zinc-induced analgesia. These results provide a molecular mechanism for the pain-relieving properties of dietary zinc and strengthen the notion that zinc therapy may successfully treat intractable pain, such as fibromyalgia 36 , peripheral neuropathy 37 or other pain abnormalities 38 . The zinc phenotype of mutant mice also reveals a largely unanticipated key role of NR2A-containing receptors in pain processing. The involvement of diheteromeric NR1-NR2A receptors containing two copies of the zinc-sensitive NR2A subunit is most probable. In addition, triheteromeric receptors that incorporate both NR2A and non-NR2A subunits and represent a substantial fraction of NMDARs 39, 40 could also contribute, although their zinc sensitivity is lower 41 . There is evidence for the therapeutic utility of NR2B-selective antagonists as analgesics that limit the severe consequences of general NMDAR blockade 14, 42 . Our finding calls for new strategies that selectively target zinc-sensitive NR2A-containing receptors for controlling persistent pain states.
DISCUSSION
The striking pain phenotype observed in knock-in NR2A-H128S mice shows that high-affinity Zn 2+ binding to the NR2A subunit is sufficient to dampen NMDAR function in pain pathways. As the NR2A-H128S mutation eliminates sensitivity of NMDARs to nanomolar, but not micromolar, zinc concentrations [18] [19] [20] , our data strongly suggest that extracellular zinc levels that fine-tune NMDAR activity in vivo are in the submicromolar range. Endogenous zinc, therefore, regulates NMDAR function at concentrations far lower than previous estimations 2, 3 . The origin of zinc diffusing in the vicinity of NMDARs is yet to be determined. Zn 2+ ions that are stored with glutamate in synaptic vesicles and released during neuronal activity are obvious candidates 23 . Inhibitory GABAergic neurons, which in the spinal cord form a major contingent of zinc-containing terminals 43 , may provide additional sources of zinc. Finally, NMDA-dependent spinal long-term potentiation is well recognized as a cellular substrate for hyperalgesia 44 and is blocked by exogenous zinc 4 . Future experiments using NR2A-H128S mutant mice will determine the role of endogenous zinc acting at NR2A subunits in spinal plasticity. Altogether, our data show that high-affinity Zn 2+ binding to the NR2A subunit is a fundamental molecular event in principal aspects of pain transmission, chronic pain development and zinc-induced analgesia. This discovery has important implications for pain physiopathology and its management in the clinic.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
